Kazuho Maeda

Kazuho Maeda

Auto-generated profile, based on publicly available information

Kazuho Maeda

Department of Legal Medicine, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, Kanagawa 236-0004, Japan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2025 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
KMKazuho Maeda
Kazuho Maeda
KMKei Miyakawa
Kei Miyakawa
MMMomoka Mano
Momoka Mano
HKHikaru Kuninaka
Hikaru Kuninaka
NONoriko Ogawa
Noriko Ogawa
YIYoko Ihama
Yoko Ihama
The SARS-CoV-2 pandemic has resulted in millions of deaths worldwide. However, the risk of transmission from COVID-19 corpses remain unclear, posing challenges for forensic medicine in establishing effective infection control measures during autopsies. This study aimed to investigate the presence of infectious SARS-CoV-2 in corpses and identify factors affecting viral infectivity. External examinations of 76 corpses with COVID-19 were performed, and nasopharyngeal, perioral, hand swabs, serum, cerebrospinal fluid (CSF), and urine samples were collected. Viral RNA was quantified by using digital PCR, and infectious viruses were assessed via isolation. Multivariate logistic regression analysis was used to identify factors associated with viral infectivity. Infectious viruses were isolated from the nasopharynx (51%), perioral region (10.3%), and hands (1.8%). Common predictive factors for nasopharyngeal and perioral viral infectivity were a higher viral load and shorter time from symptom onset. Detectable viral RNA in serum was also associated with nasopharyngeal infectivity. No infectious viruses were detected in serum, CSF, or urine samples. Infectious SARS-CoV-2 was detected in the nasopharynx and on the surface of COVID-19 corpses. Viral infectivity correlated with viral load and time from symptom onset, highlighting the importance of strict infection control when handling COVID-19 corpses.

3 June 2026 in Legal Medicine
Verified
Journal Article
Open access
KMKazuho Maeda
Kazuho Maeda
NONoriko Ogawa
Noriko Ogawa
MMMomoka Mano
Momoka Mano
HKHikaru Kuninaka
Hikaru Kuninaka
MMMoe Mukai
Moe Mukai
IIIhama Ihama
Ihama Ihama
RNAemia, defined as the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in blood, is correlated with the severity of coronavirus disease 2019 (COVID-19). Although serum or plasma is commonly used for viral RNA extraction in clinical studies, separating serum in forensic postmortem specimens is often difficult because of postmortem changes. This study aimed to establish an efficient method for extracting SARS-CoV-2 RNA from postmortem whole blood and assess its forensic applicability using actual case specimens. Three extraction methods-acid guanidinium thiocyanate-phenol-chloroform (AGPC), spin column (SC), and magnetic bead method-were compared to identify an efficient approach for SARS-CoV-2 RNA extraction from whole blood. The AGPC method yielded the highest viral RNA recovery, although reproducibility was limited. We therefore evaluated a modified AGPC-SC method, in which whole blood was homogenized, subjected to AGPC phase separation, and purified using the SC method. This procedure maintained the yield of viral RNA while improving reproducibility. The optimized method showed a positive percent agreement of 85.3% and a negative percent agreement of 92.5% for postmortem whole blood samples from COVID-19 cases compared with serum. Whole blood and serum viral RNA loads were strongly correlated (Spearman's ρ = 0.9014), with a small mean difference on Bland-Altman analysis (-0.053 log10 copies/µL). Thus, postmortem whole blood may serve as an alternative to serum, and the AGPC-SC method involving homogenization provides a practical approach for SARS-CoV-2 RNA extraction in forensic practice.